CATALOGO DEI PRODOTTI DELLA RICERCA

OPPICI, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.547
EU - Europa 1.923
AS - Asia 1.663
SA - Sud America 211
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 43
OC - Oceania 1
Totale 6.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.467
RU - Federazione Russa 794
CN - Cina 627
SG - Singapore 559
GB - Regno Unito 381
IT - Italia 204
BR - Brasile 167
VN - Vietnam 150
HK - Hong Kong 129
SE - Svezia 108
DE - Germania 88
FR - Francia 87
IE - Irlanda 78
FI - Finlandia 62
KR - Corea 50
CA - Canada 44
IN - India 30
BE - Belgio 23
JP - Giappone 22
UA - Ucraina 21
BD - Bangladesh 18
NL - Olanda 18
ID - Indonesia 17
AR - Argentina 14
ES - Italia 14
NG - Nigeria 13
IQ - Iraq 12
PL - Polonia 12
EC - Ecuador 11
IL - Israele 9
TR - Turchia 9
ZA - Sudafrica 9
MX - Messico 8
PK - Pakistan 8
CR - Costa Rica 7
CW - ???statistics.table.value.countryCode.CW??? 6
VE - Venezuela 6
AT - Austria 5
GR - Grecia 5
HN - Honduras 5
LT - Lituania 5
JM - Giamaica 4
PH - Filippine 4
SV - El Salvador 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
KE - Kenya 3
MA - Marocco 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
UY - Uruguay 3
UZ - Uzbekistan 3
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
LV - Lettonia 2
MY - Malesia 2
PR - Porto Rico 2
SC - Seychelles 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
CG - Congo 1
CM - Camerun 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GL - Groenlandia 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 6.396
Salva come PNG Salva come JPEG
Città #
Ashburn 318
Southend 313
Singapore 290
Moscow 254
Dallas 253
Chandler 251
San Jose 222
Woodbridge 138
Ann Arbor 133
Beijing 126
Hong Kong 126
Verona 111
Jacksonville 106
Dublin 78
Council Bluffs 71
The Dalles 59
Jinan 52
New York 51
Ho Chi Minh City 43
Houston 40
Nanjing 38
Los Angeles 35
Lawrence 33
Princeton 33
Shenyang 32
Hanoi 31
Hebei 30
Wilmington 29
Santa Clara 27
Columbus 23
Tianjin 23
Haikou 21
Seattle 21
São Paulo 21
Brussels 20
Zhengzhou 20
Tokyo 19
Ningbo 18
Buffalo 17
Helsinki 17
Changsha 16
Seoul 16
Montreal 15
Munich 15
Milan 14
Nanchang 14
Taizhou 14
Dong Ket 13
Hangzhou 13
Guangzhou 12
Jakarta 12
Lanzhou 12
Abuja 11
Brooklyn 11
Redondo Beach 11
San Francisco 11
Stockholm 11
Belo Horizonte 10
Boardman 10
Chennai 10
Fuzhou 9
Jiaxing 9
Taiyuan 9
Amsterdam 8
Toronto 8
Warsaw 8
Da Nang 7
Denver 7
Kent 7
Las Vegas 7
London 7
Norwalk 7
Orem 7
Phoenix 7
Atlanta 6
Frankfurt am Main 6
Johannesburg 6
Redwood City 6
Willemstad 6
Boston 5
Dearborn 5
Mumbai 5
Quito 5
Redmond 5
San José 5
Athens 4
Biên Hòa 4
Brescia 4
Cagliari 4
Chicago 4
Falkenstein 4
Lancaster 4
Madrid 4
Newark 4
Perugia 4
Qingdao 4
Rio de Janeiro 4
Riva 4
Rome 4
San Salvador 4
Totale 4.021
Salva come PNG Salva come JPEG
Nome #
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase 322
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 279
Molecular and cellular insights into defects of human alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I 252
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 234
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 232
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine 216
A novel pathway for metabolism of the cardiovascular risk factor homoarginine by alanine:glyoxylate aminotransferase 2 214
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 213
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 211
Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism 209
Folding defects leading to primary hyperoxaluria 208
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 206
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 205
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 203
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 198
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. 190
Metastatic breast cancer cells enter into dormant state and express cancer stem cells phenotype under chronic hypoxia 189
Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6 188
Evolutionary divergent suppressor mutations in conformational diseases 184
Dimerization drives proper folding of human Alanine:Glyoxylate aminotransferase but is dispensable for peroxisomal targeting 184
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I 178
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation. 178
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 178
Biochemical properties and oxalate-degrading activity of oxalate decarboxylase from Bacillus Subtilis at neutral pH 178
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses 169
Natural and unnatural compounds rescue folding defects of human alanine:glyoxylate aminotransferase leading to Primary Hyperoxaluria Type I 167
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 164
Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I 162
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 161
A novel p.(Glu111Val) missense mutation in GUCA1A associated with cone-rod dystrophy leads to impaired calcium sensing and perturbed second messenger homeostasis in photoreceptors 160
Molecular basis of primary hyperoxaluria: clues to innovative treatments 155
Molecular insights into primary hyperoxaluria Type I pathogenesis. 134
Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I. 134
Totale 6.455
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.358
article - articoli 18.326
book - libri 0
conference - conferenze 780
curatela - curatele 0
other - altro 635
patent - brevetti 0
selected - selezionate 0
volume - volumi 617
Totale 40.716
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022132 0 0 0 0 7 3 6 20 16 8 12 60
2022/2023660 40 88 54 118 62 135 15 41 70 1 21 15
2023/2024262 16 13 11 15 30 50 5 35 5 15 48 19
2024/2025842 41 49 22 138 69 31 66 29 150 51 74 122
2025/20262.595 176 95 285 370 685 198 204 131 194 161 34 62
2026/2027407 22 39 96 226 24 0 0 0 0 0 0 0
Totale 6.455